LifeVantage executives will present at H.C. Wainwright's investment conference on September 10, 2025, in New York.
Quiver AI Summary
LifeVantage Corporation, a health and wellness company specializing in cellular health products, announced that CEO Steve Fife and CFO Carl Aure will be participating in the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025, in New York City. They are scheduled to present and meet with investors on September 10 at 1:00 p.m. Eastern Time. A live webcast of their presentation will be available on the company's Investor Relations website, and a replay will be accessible for 90 days afterward. LifeVantage focuses on nutrigenomics and offers a range of health products, including the Protandim® family, TrueScience® products, and various nutritional supplements, while also providing business opportunities for independent consultants. Founded in 2003, the company is based in Lehi, Utah.
Potential Positives
- Participation of top executives in a significant investment conference enhances company visibility and investor engagement.
- The presentation at the H.C. Wainwright conference demonstrates LifeVantage's commitment to communicating its business strategy and innovations to potential investors.
- Access to a live webcast and archived presentation broadens reach and provides transparency to investors and stakeholders.
- Highlighting the company's expertise in nutrigenomics emphasizes its innovative position in the health and wellness market, potentially attracting interest from health-conscious consumers and investors alike.
Potential Negatives
- Participation in the H.C. Wainwright Global Investment Conference may highlight the need for external validation of the company's strategies and products, possibly suggesting internal struggles in gaining market confidence.
- Dependence on a live webcast for investor engagement might indicate a limited in-person outreach strategy, which can be perceived as a lack of transparency or accessibility.
- The focus on specific product lines such as Protandim® and the MindBody GLP-1 System™ may inadvertently highlight a reliance on a narrow product portfolio, raising concerns about diversification and overall market resilience.
FAQ
What is the date and location of the H.C. Wainwright Conference?
The H.C. Wainwright 27th Annual Global Investment Conference will be held from September 8-10, 2025, in New York, NY.
Who from LifeVantage will present at the conference?
Steve Fife, President and CEO, and Carl Aure, CFO, will represent LifeVantage at the conference.
When is LifeVantage's presentation scheduled?
The presentation is scheduled for approximately 1:00 p.m. Eastern Time on Wednesday, September 10, 2025.
Where can I watch the LifeVantage presentation?
A live webcast of the presentation will be available on the Company’s Investor Relations website.
How long will the conference webcast be available for replay?
The webcast replay will be archived and accessible for approximately 90 days after the event.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$LFVN Insider Trading Activity
$LFVN insiders have traded $LFVN stock on the open market 10 times in the past 6 months. Of those trades, 9 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $LFVN stock by insiders over the last 6 months:
- CARL AURE (Chief Financial Officer) sold 2,746 shares for an estimated $36,768
- GARRY PAUL MAURO has made 7 purchases buying 2,150 shares for an estimated $26,337 and 0 sales.
- DARWIN LEWIS has made 2 purchases buying 379 shares for an estimated $4,873 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LFVN Hedge Fund Activity
We have seen 69 institutional investors add shares of $LFVN stock to their portfolio, and 49 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL MANAGEMENT CORP /VA added 550,607 shares (+77.0%) to their portfolio in Q2 2025, for an estimated $7,201,939
- DRIEHAUS CAPITAL MANAGEMENT LLC removed 459,619 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,011,816
- BLACKROCK, INC. added 389,036 shares (+184.6%) to their portfolio in Q2 2025, for an estimated $5,088,590
- SUSQUEHANNA INTERNATIONAL GROUP, LLP removed 237,073 shares (-77.0%) from their portfolio in Q2 2025, for an estimated $3,100,914
- GEODE CAPITAL MANAGEMENT, LLC added 126,274 shares (+106.1%) to their portfolio in Q2 2025, for an estimated $1,651,663
- RUSSELL INVESTMENTS GROUP, LTD. removed 106,200 shares (-93.0%) from their portfolio in Q2 2025, for an estimated $1,389,096
- MILLENNIUM MANAGEMENT LLC added 91,001 shares (+45.4%) to their portfolio in Q2 2025, for an estimated $1,190,293
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SALT LAKE CITY, Sept. 02, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the H.C. Wainwright 27th Annual Global Investment Conference, to be held September 8-10, 2025 in New York, NY.
Mr. Fife and Mr. Aure will meet with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, September 10, 2025. A live webcast of their presentation will be accessible on the News & Events section of the Company’s Investor Relations website at https://lifevantage.gcs-web.com/ or directly here . A replay of the webcast will be archived and can be accessed for approximately 90 days on the Company’s website.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com .
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
[email protected]
